Home

RxSight, Inc. - Common Stock (RXST)

16.26
+0.05 (0.31%)
NASDAQ · Last Trade: Apr 4th, 5:06 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to RxSight, Inc. - Common Stock (RXST)

Alcon Inc. ALC -6.46%

Alcon Inc. is a major player in the eye care market and competes with RxSight by offering a wide range of ophthalmic surgical products, including lenses and surgical devices. Alcon's established presence and extensive product portfolio provide it with a significant competitive advantage in terms of brand recognition and distribution channels. Additionally, their substantial investment in research and development allows them to innovate continually, which can outperform smaller competitors like RxSight.

Bausch Health Companies Inc. BHC -6.00%

Bausch Health operates in the ophthalmic space through its Bausch + Lomb division, competing with RxSight by offering a wide array of products, including intraocular lenses. Their established brand reputation and experience in the healthcare market give them a substantial advantage. Bausch Health's focus on both existing products and new technology ensures they have a robust pipeline, enabling them to compete effectively against RxSight's more focused offerings.

Carl Zeiss AG CZMWF +0.00

Carl Zeiss AG is a leading manufacturer of optical systems that includes a division focused on ophthalmology. They compete with RxSight through their advanced intraocular lenses and surgical tools that often incorporate cutting-edge technology. Carl Zeiss' longstanding reputation for precision and quality in optics provides them a significant competitive advantage. Their global reach and alliances with eye care professionals further enhance their competitive position relative to RxSight.

Hoya Corporation HOCPY -3.92%

Hoya Corporation operates in the healthcare sector, offering products such as intraocular lenses and other surgical solutions for eye care. They compete with RxSight by emphasizing product quality and patient outcomes. Their strong focus on international markets allows them to leverage economies of scale, which can provide a cost advantage. Though RxSight has innovative products, Hoya’s market experience and operational efficiencies give them an edge.

Johnson & Johnson Surgical Vision JNJ -4.12%

Johnson & Johnson Surgical Vision, a subsidiary of Johnson & Johnson, offers a comprehensive lineup of products for cataract and refractive eye surgery. They compete with RxSight by leveraging their vast resources and existing relationships within healthcare systems to promote their products effectively. Their long history in the medical field, along with a strong marketing budget, provides them with a robust competitive edge over RxSight, particularly in gaining surgeon and hospital partnerships.